D
NP Life Sciences Health Industry Group Inc.
NPLS
$0.0539
-$0.0962-64.09%
D
Sell
4/19/2024Downgrade
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to D from D+ on 4/19/2024 due to a significant decline in the efficiency index and total return index. Total capital declined 28.47% from $54.1 to $38.7.
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to D from D+ on 4/19/2024 due to a significant decline in the efficiency index and total return index. Total capital declined 28.47% from $54.1 to $38.7.
D
Sell
11/21/2023Downgrade
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to D+ from C- on 11/21/2023 due to a large decline in the growth index, total return index and volatility index. Earnings per share declined from $0.0017 to -$0.0009, EBIT declined 152.38% from $71.4 to -$37.4, and total revenue declined 83.66% from $107.1 to $17.5.
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to D+ from C- on 11/21/2023 due to a large decline in the growth index, total return index and volatility index. Earnings per share declined from $0.0017 to -$0.0009, EBIT declined 152.38% from $71.4 to -$37.4, and total revenue declined 83.66% from $107.1 to $17.5.
C
Hold
7/5/2023Upgraded
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to C- from E+ on 7/5/2023 due to a significant increase in the efficiency index and total return index. Total capital increased 6.22% from $19.3 to $20.5.
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to C- from E+ on 7/5/2023 due to a significant increase in the efficiency index and total return index. Total capital increased 6.22% from $19.3 to $20.5.
E
Sell
4/21/2023Downgrade
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to E+ from D on 4/21/2023 due to a significant decline in the valuation index, solvency index and total return index.
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to E+ from D on 4/21/2023 due to a significant decline in the valuation index, solvency index and total return index.
D
Sell
3/14/2023Downgrade
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to D from D+ on 3/14/2023 due to a major decline in the total return index.
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to D from D+ on 3/14/2023 due to a major decline in the total return index.
D
Sell
2/23/2023Upgraded
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to D+ from D on 2/23/2023 due to an increase in the total return index.
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to D+ from D on 2/23/2023 due to an increase in the total return index.
D
Sell
2/8/2023Downgrade
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to D from D+ on 02/08/2023.
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to D from D+ on 02/08/2023.
D
Sell
11/21/2022Upgraded
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to D+ from D on 11/21/2022 due to a significant increase in the valuation index, growth index and total return index. Total revenue increased 173.33% from $15 to $41, and operating cash flow increased 128.44% from -$22.5 to $6.4.
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to D+ from D on 11/21/2022 due to a significant increase in the valuation index, growth index and total return index. Total revenue increased 173.33% from $15 to $41, and operating cash flow increased 128.44% from -$22.5 to $6.4.
D
Sell
5/24/2022Upgraded
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to D from D- on 05/24/2022.
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to D from D- on 05/24/2022.
D
Sell
5/13/2022Downgrade
GJ Culture Group US, Inc. (GJCU) was downgraded to D- from D+ on 5/13/2022 due to a decline in the volatility index and total return index.
GJ Culture Group US, Inc. (GJCU) was downgraded to D- from D+ on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/4/2022Upgraded
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to D+ from D- on 05/04/2022.
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to D+ from D- on 05/04/2022.
D
Sell
5/3/2022Downgrade
GJ Culture Group US, Inc. (GJCU) was downgraded to D- from D+ on 5/3/2022 due to a decline in the total return index.
GJ Culture Group US, Inc. (GJCU) was downgraded to D- from D+ on 5/3/2022 due to a decline in the total return index.
D
Sell
5/2/2022Upgraded
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to D+ from D- on 05/02/2022.
NP Life Sciences Health Industry Group Inc. (NPLS) was upgraded to D+ from D- on 05/02/2022.
D
Sell
4/20/2022Downgrade
GJ Culture Group US, Inc. (GJCU) was downgraded to D- from D on 4/20/2022 due to a significant decline in the volatility index.
GJ Culture Group US, Inc. (GJCU) was downgraded to D- from D on 4/20/2022 due to a significant decline in the volatility index.
D
Sell
11/3/2021Upgraded
GJ Culture Group US, Inc. (GJCU) was upgraded to D from D- on 11/3/2021 due to an increase in the growth index and total return index.
GJ Culture Group US, Inc. (GJCU) was upgraded to D from D- on 11/3/2021 due to an increase in the growth index and total return index.
D
Sell
7/1/2021Upgraded
GJ Culture Group US, Inc. (GJCU) was upgraded to D- from E+ on 7/1/2021 due to a large increase in the total return index and volatility index.
GJ Culture Group US, Inc. (GJCU) was upgraded to D- from E+ on 7/1/2021 due to a large increase in the total return index and volatility index.
E
Sell
4/1/2021Upgraded
GJ Culture Group US, Inc. (GJCU) was upgraded to E+ from E on 4/1/2021 due to a significant increase in the volatility index and total return index.
GJ Culture Group US, Inc. (GJCU) was upgraded to E+ from E on 4/1/2021 due to a significant increase in the volatility index and total return index.
E
Sell
1/19/2021None
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to E from U on 01/19/2021.
NP Life Sciences Health Industry Group Inc. (NPLS) was downgraded to E from U on 01/19/2021.
OTC PK
07/15/2024 3:14PM Eastern
Quotes delayed